Suppr超能文献

热消融与手术切除异时性结直肠癌肝转移的临床疗效比较

[Comparison of Clinical Efficacy of Thermal Ablation vs. Surgical Resection of Metachronous Colorectal Liver Metastasis].

作者信息

Yao Zhi-Hang, Zhang Kai, Luo Yin-Gen, Li Yu-Jie, Yang Chao, Yang Hong-Cai, Cong Tian-Hao, Li Xiao

机构信息

Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.

Department of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital/National Clinical Research Center for Cancer//Tianjin Municipal Key Laboratory of Cancer Prevention and Treatment/Tianjin Municipal Clinical Research Center for Cancer, Tianjin 300060, China.

出版信息

Sichuan Da Xue Xue Bao Yi Xue Ban. 2022 May;53(3):481-487. doi: 10.12182/20220560107.

Abstract

OBJECTIVE

To compare the treatment efficacy of thermal ablation versus surgical resection of metachronous colorectal liver metastasis (CRLM) and to explore the potential candidates suited for thermal ablation.

METHODS

The data of 319 patients with CRLM who underwent radical treatment at the Cancer Hospital, Chinese Academy of Medical Sciences between November 2007 and January 2021 were retrospectively collected. The patients were divided into two groups, the thermal ablation group and the surgical resection group, according to the actual treatments they received. Propensity score matching (PSM) was applied to balance the baseline characteristics between the two groups. Cox regression analysis was conducted to identify the risk factors for recurrence and survival. Survival analysis was performed for intergroup comparison.

RESULTS

Using PSM at 1∶1 ratio, 92 patients were included in the thermal ablation group and 92 patients were included in the surgical resection group.The median overall survival (OS) in the thermal ablation group was 49 (95% confidence interval, 37-76) months, which was shorter than that of the surgical resection group ( <0.01). Multivariate Cox regression analysis indicated that the T staging of primary tumor, number of metastatic tumor, maximum diameter of metastatic tumor, preoperative serum carcinoembryonic antigen (CEA) level, and treatment method were independent risk factors affecting OS. Compared with the surgical resection group, the thermal ablation group demonstrated higher hepatic recurrence rate (59.8% vs. 23.9%, <0.01), shorter disease-free survival (DFS) (10 months vs. 33 months, <0.01), and shorter length of hospital stay (7 days vs. 14 days, <0.01). Subgroup analysis, conducted with the data of the 319 patients before PSM, showed that early recurrence patients who underwent thermal ablation or surgical resection had comparable median OS (29 months vs. 42 months, =0.35). For the non-early recurrence patients, the median OS of the thermal ablation group was shorter than that of the surgical resection group ( <0.01).

CONCLUSION

For the treatment of CRLM, the efficacy of surgical resection was better than that of thermal ablation. However, the efficacy was comparable between the two treatments for early recurrence patients of CRLM.

摘要

目的

比较热消融与手术切除治疗异时性结直肠癌肝转移(CRLM)的疗效,并探索适合热消融的潜在候选者。

方法

回顾性收集2007年11月至2021年1月在中国医学科学院肿瘤医院接受根治性治疗的319例CRLM患者的数据。根据患者实际接受的治疗,将其分为两组,即热消融组和手术切除组。应用倾向评分匹配(PSM)来平衡两组之间的基线特征。进行Cox回归分析以确定复发和生存的危险因素。进行生存分析以进行组间比较。

结果

以1∶1的比例进行PSM后,热消融组纳入92例患者,手术切除组纳入92例患者。热消融组的中位总生存期(OS)为49(95%置信区间,37 - 76)个月,短于手术切除组(<0.01)。多因素Cox回归分析表明,原发肿瘤的T分期、转移瘤数量、转移瘤最大直径、术前血清癌胚抗原(CEA)水平和治疗方法是影响OS的独立危险因素。与手术切除组相比,热消融组肝复发率更高(59.8%对23.9%,<0.01),无病生存期(DFS)更短(10个月对33个月,<0.01),住院时间更短(7天对14天,<0.01)。对PSM前319例患者的数据进行亚组分析显示,接受热消融或手术切除的早期复发患者的中位OS相当(29个月对42个月,=0.35)。对于非早期复发患者,热消融组的中位OS短于手术切除组(<0.01)。

结论

对于CRLM的治疗,手术切除的疗效优于热消融。然而,对于CRLM的早期复发患者,两种治疗的疗效相当。

相似文献

本文引用的文献

6
Liver metastases.肝转移。
Nat Rev Dis Primers. 2021 Apr 15;7(1):27. doi: 10.1038/s41572-021-00261-6.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验